Johnson's Antiseptic Wound Powder 2% w/w, Cutaneous Powder

Држава: Велика Британија

Језик: Енглески

Извор: VMD (Veterinary Medicines Directorate)

Активни састојак:

Chloramine T

Доступно од:

Johnson's Veterinary Products Ltd

АТЦ код:

amended)

INN (Међународно име):

Chloramine T

Фармацеутски облик:

Cutaneous powder

Тип рецептора:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Терапеутска група:

Cats, Dogs

Терапеутска област:

Antiseptic

Статус ауторизације:

Suspended

Датум одобрења:

1999-01-22

Карактеристике производа

Revised: March 2010
(ATCVet code amended)
SUMMARY OF PRODUCT CHARACTERISTICS
1.
Name of the Veterinary Medicinal Product:
Johnson's Antiseptic Wound Powder 2% w/w, Cutaneous powder
2.
Qualitative and Quantitative Composition:
Active Ingredient:
Tosylchloramide Sodium 2% w/w
For full list of excipients, see section 6.1.
3.
Pharmaceutical form:
Cutaneous powder.
A fine, white powder with odour characteristic of chloramine.
4.
Clinical particulars:
4.1
Target species:
Dogs and Cats.
4.2
Indications for use, specifying the target species:
Antiseptic dry dressing for minor wounds and abrasions of dogs and
cats.
4.3
Contra-Indications:
None known.
4.4
Special warnings for each target species:
Topical hypersensitivity reactions may occur; rare; severity: may
manifest by
reddening and scaling of affected skin, eczematous exacerbation of the
lesion,
or as a failure to heal.
Anaphylaxis may rarely occur, theoretically.
Prolonged
use
may
result
in
delayed
healing
and/or
overgrowth
of
non-
susceptible organisms.
4.5
Special precautions for use:
i)
Special precautions for use in animals:
For external use only.
If condition fails to improve within 7 days consult a veterinary
surgeon.
Revised: March 2010
(ATCVet code amended)
ii)
Special precautions to be taken by the person administering the
medicinal
product to animals:
Avoid contact with eyes. If contact with eyes occurs, wash with
copious
amounts of water.
Avoid inhaling powder. If ingested, seek medical advice immediately.
Wash hands after use.
4.6
Adverse reactions (frequency and seriousness)
None reported.
4.7
Use during pregnancy, lactation or lay:
No restrictions necessary.
4.8
Interaction with other medicinal products and other forms of
interaction:
None reported.
4.9
Amounts to be administered and administration route:
As dusting powder to wounds and abrasions. Wounds should be thoroughly
cleansed prior to application of the wound powder.
4.10
Overdose (symptoms, emergency procedures, antidotes) if necessary:
None stated.
4.11
Withdrawal periods:
Not applicable.
5.
P